218 results
Page 7 of 11
8-K
EX-99.1
0nrcr1evfyekwl4
30 Oct 19
Biogen and Alkermes Announce FDA Approval of VUMERITY™ (diroximel fumarate) for Multiple Sclerosis
7:43am
8-K
EX-99.1
3vkmgf
23 Oct 19
Alkermes Plc Reports Third Quarter 2019 Financial Results and Implementation of Restructuring
7:05am
8-K
EX-99.2
l1mhs
23 Oct 19
Alkermes Plc Reports Third Quarter 2019 Financial Results and Implementation of Restructuring
7:05am
8-K
EX-99.1
sygs7pjvttob
30 Jul 19
Regulation FD Disclosure
7:46am
8-K
EX-99.1
98cpmls9 sisac
25 Jul 19
Alkermes Plc Reports Second Quarter 2019 Financial Results
7:05am
8-K
EX-99.2
965nw41m1yl8aruy 6a
25 Jul 19
Alkermes Plc Reports Second Quarter 2019 Financial Results
7:05am
8-K
EX-10.1
vwmz4z881itwp2l64y
22 May 19
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
novng3z5k4k nq
25 Apr 19
Alkermes Plc Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.2
a0o12gz
25 Apr 19
Alkermes Plc Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.2
09oxxxl44asr2w
14 Feb 19
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
3zt4 5xm8
14 Feb 19
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
vpwa7mr9j6qp 61
7 Jan 19
Results of Operations and Financial Condition
7:13am
8-K
EX-99.2
ykzeck7jlx5sz7
23 Oct 18
Results of Operations and Financial Condition
8:15am
8-K
EX-99.1
l8zc 8y3heb4
23 Oct 18
Results of Operations and Financial Condition
8:15am